Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk NOT-CA-23-089 09/08/2024 Edward Sauter, M.D., Ph.D.
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 09/08/2024
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 01/08/2026 Sharon Ross, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 07/02/2025 Matthew Young, Ph.D.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 Clinical Trial Not Allowed 05/16/2024
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202 Clinical Trial Not Allowed 04/16/2025 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 06/12/2024
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities PAR-22-064 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2025
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research RFA-CA-24-013 (U01 Clinical Trial Optional) U01 Clinical Trial Optional 10/02/2024 Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research RFA-CA-24-012 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 10/02/2024 Guillermo Marquez, Ph.D.